Key result
Monocytes contribute to thrombotic disorders by providing tissue factor, forming prothrombotic monocyte-platelet aggregates, linking inflammation to procoagulant states, and aiding recanalisation.
This review highlights the multifaceted role of monocytes in thrombotic disorders, extending beyond innate immunity to include prothrombotic and thrombus recanalisation processes.
Monocyte-targeted interventions should not yet alter thrombotic disorder management; extends mechanistic insights but leaves open prospective validation.
Although, the main physiological role of monocytes is attributed to innate immunity (that is, phagocytosis) and the development of tissue macrophages and dendritic cells, the pathophysiological role of these goes far behind these (simplistic) limits. Indeed, monocytes constitute a major source of blood tissue factor, a key element of the extrinsic coagulation cascade. Monocytes actively bind to platelets, thus forming very prothrombotic monocyte-platelet aggregates. Additionally, these cells link inflammation and the procoagulant state observed in various prothrombotic conditions. However, monocytes are also crucial for successful thrombus recanalisation. In this article, we review the available data on potential mechanisms that link monocytes with thrombosis-related processes.
No takes yet. Share an insight, caveat, or question.
Lip et al. (2009) conducted a review in Thrombotic disorders. Monocytes was evaluated. Monocytes contribute to thrombotic disorders by providing tissue factor, forming prothrombotic monocyte-platelet aggregates, linking inflammation to procoagulant states, and aiding recanalisation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: